mesoblast

Recon

Josh SandbergApril 1, 2016
1 2,215

Mesoblast Cell Therapy Shows Disease Modifying Effects on Knee Osteoarthritis

NEW YORK and MELBOURNE, Australia, April 01, 2016 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that results from…
Read More »
Josh SandbergApril 9, 2014
855

Osiris Therapeutics receives $15 million cash payment from Mesoblast for Prochymal

Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic…
Read More »
Spine

Josh SandbergApril 17, 2012
840

Intervertebral Disc Repair Phase 2 Trial Update

MELBOURNE, Australia, April 17, 2012 /PRNewswire via COMTEX/ — Global regenerative medicine company Mesoblast Limited (asx:MSB) today announced that its…
Read More »
Josh SandbergAugust 22, 2011
723

First Minimally-Invasive Procedure Performed in Mesoblast’s Phase 2 Stem Cell Trial for Lumbar Disc Repair

MELBOURNE, Australia, Aug. 22, 2011 /PRNewswire/ — Regenerative medicine company, Mesoblast Limited (ASX:MSB), today announced that the first minimally-invasive lumbar disc procedure…
Read More »
Josh SandbergMarch 3, 2010
890

Mesoblast Limited (ASX:MSB) Key Bone Repair Patent Granted In The United States

Melbourne, Mar 3, 2010 – (ABN Newswire< http://www.abnnewswire.net/index.asp?lang=>) – Australia’s regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that…
Read More »